v3.26.1
Investments, at Fair Value (Details)
$ / shares in Units, $ in Thousands
 3 Months Ended
Feb. 05, 2026
USD ($)
Feb. 05, 2026
ILS (₪)
Dec. 29, 2025
USD ($)
Dec. 29, 2025
ILS (₪)
Oct. 01, 2025
$ / shares
shares
Sep. 14, 2025
USD ($)
Jan. 02, 2025
USD ($)
shares
Sep. 04, 2024
USD ($)
Sep. 21, 2023
USD ($)
Mar. 31, 2026
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
shares
Sep. 14, 2025
ILS (₪)
Sep. 04, 2024
ILS (₪)
Investments, at Fair Value [Line Items]                            
Cash                   $ 6,500        
Vest exercised amount             $ 500              
Per share (in Dollars per share) | $ / shares                   $ 2.85        
Percentage of discount rate                   32.00%        
Fair value and aggregate unpaid principal balance                   $ 2,909   $ 4,488    
Prepaid expenses                   450   449    
Financial income (expenses)                   $ (100) $ (143)      
Percentage of beneficial ownership                   9.99%        
Percentage of project profits               40.00%            
Amount on consideration     $ 2,185 ₪ 7,000                    
Fund amount $ (499) ₪ 1,556                        
Total proceeds for warrants                   $ 50,678   $ 10,119    
Tranche A Note [Member]                            
Investments, at Fair Value [Line Items]                            
Reduction of principal balance                   $ 22,500        
Tranche B [Member]                            
Investments, at Fair Value [Line Items]                            
Percentage of interest senior secured convertible notes issued                   50.00%        
Percentage of discount rate                   107.47%        
Tranche B Warrants [Member]                            
Investments, at Fair Value [Line Items]                            
Warrant per share (in Dollars per share) | $ / shares                   $ 36.4        
Tranche A Note [Member]                            
Investments, at Fair Value [Line Items]                            
Reduction of principal balance                   $ 2,500        
Percentage of tranche purchased                   4.00%        
Warrants [Member]                            
Investments, at Fair Value [Line Items]                            
Warrants to purchase shares (in Shares) | shares                       20,000    
Per share (in Dollars per share) | $ / shares         $ 20                  
2023 Scilex Transaction [Member]                            
Investments, at Fair Value [Line Items]                            
Principal of note issued                 $ 101,875          
Maturity date                 Mar. 21, 2025          
Interest bearing percentage                 8.50%          
Convertible Notes SPA [Member]                            
Investments, at Fair Value [Line Items]                            
Aggregate principal amount                   $ 25,000        
Tranche B Note Consent [Member]                            
Investments, at Fair Value [Line Items]                            
Principal of note issued             500              
Cash             $ 877              
Royalty Percentage             2.00%              
Profit Sharing Loan Agreement [Member]                            
Investments, at Fair Value [Line Items]                            
Percentage of annual interest of loan principal               20.00%            
Loan [Member]                            
Investments, at Fair Value [Line Items]                            
Percentage of annual interest of loan principal           6.00%                
Additional loan           $ 150             ₪ 500,000  
Royalty Purchase Agreement [Member] | Common Stock [Member] | Tranche B Note Consent [Member]                            
Investments, at Fair Value [Line Items]                            
Common stock (in Shares) | shares             71,429              
Expected Term [Member] | Profit Sharing Loan Agreement [Member]                            
Investments, at Fair Value [Line Items]                            
Risk-neutral probabilities method, measurement input                   2.76        
Curve Rate [Member] | Profit Sharing Loan Agreement [Member]                            
Investments, at Fair Value [Line Items]                            
Risk-neutral probabilities method, measurement input                   16.22        
Risk Spread [Member] | Profit Sharing Loan Agreement [Member]                            
Investments, at Fair Value [Line Items]                            
Risk-neutral probabilities method, measurement input                   0.43        
Scilex [Member]                            
Investments, at Fair Value [Line Items]                            
Repaid principal amount outstanding                   $ 13,000        
Remaining principal balance                   12,000        
Scilex [Member] | Tranche B Note [Member]                            
Investments, at Fair Value [Line Items]                            
Accrued interest                   390        
Loan Agreement [Member]                            
Investments, at Fair Value [Line Items]                            
Loan principal               $ 1,523           ₪ 5,500,000
Profit Sharing Loan Agreement [Member]                            
Investments, at Fair Value [Line Items]                            
Loan principal               1,307           4,700,000
Additional loan Agreement [Member]                            
Investments, at Fair Value [Line Items]                            
Loan principal               $ 237           ₪ 800,000
Ruby Sapphire II [Member]                            
Investments, at Fair Value [Line Items]                            
Total proceeds for warrants                   492        
2023 Scilex Transaction [Member]                            
Investments, at Fair Value [Line Items]                            
Aggregate principal amount                   7,675        
Accrued interest                   17,937        
2023 Scilex Transaction [Member] | Tranche A Note [Member]                            
Investments, at Fair Value [Line Items]                            
Refinanced amount                   25,000        
2023 Scilex Transaction [Member] | Scilex [Member]                            
Investments, at Fair Value [Line Items]                            
Repaid amount                   $ 69,200        
Scilex Transaction [Member]                            
Investments, at Fair Value [Line Items]                            
Financial income (expenses)                     $ 4,007      
Scilex Transaction [Member] | Tranche B Warrants [Member]                            
Investments, at Fair Value [Line Items]                            
Warrants to purchase shares (in Shares) | shares                   107,143        
Scilex Transaction [Member] | Scilex [Member]                            
Investments, at Fair Value [Line Items]                            
Financial income (expenses)                   $ (3,616)        
Lidocaine Topical System [Member] | Tranche B Note Consent [Member]                            
Investments, at Fair Value [Line Items]                            
Accrued interest             $ 377              
Extension Agreement [Member] | Closing Penny Warrant [Member]                            
Investments, at Fair Value [Line Items]                            
Exercisable warrants (in Shares) | shares         100,000                  
Profit Sharing Loan Agreement [Member]                            
Investments, at Fair Value [Line Items]                            
Additional loan                   $ 1,933   $ 1,890    
Minimum [Member]                            
Investments, at Fair Value [Line Items]                            
Percentage of discount rate                   107.43%        
Maximum [Member]                            
Investments, at Fair Value [Line Items]                            
Percentage of discount rate                   114.44%